Executive Solution Overview
**files (1)** – ## NU553_Unit_5_Template.docx **## NU553_Unit_5_Template.docx** **NU553 Unit 5 Template** Review the [grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx). **Communication, Shared Decision Making and Interprofessio…
Instant Solution Download
$6.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
**files (1)**
– ## NU553_Unit_5_Template.docx
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
Leave a Reply